Regarding the implications for clinical practice, TRIAD-TB offers a pragmatic, bedside-ready way to identify pulmonary TB inpatients at the highest short-term risk using data every ward already collects (vitals, CBC-derived SII, CRP, BMI, albumin) and their 72 h trajectories. The gene discussed is ALB; the disease is pulmonary tuberculosis.